Atea Pharmaceuticals Inc (AVIR)
3.82
+0.21
(+5.82%)
USD |
NASDAQ |
May 22, 16:00
3.81
-0.01
(-0.26%)
After-Hours: 20:00
Atea Pharmaceuticals Market Cap: 321.73M for May 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 22, 2024 | 321.73M |
| May 21, 2024 | 304.05M |
| May 20, 2024 | 303.20M |
| May 17, 2024 | 307.41M |
| May 16, 2024 | 311.63M |
| May 15, 2024 | 312.47M |
| May 14, 2024 | 333.52M |
| May 13, 2024 | 340.26M |
| May 10, 2024 | 327.63M |
| May 09, 2024 | 331.00M |
| May 08, 2024 | 331.00M |
| May 07, 2024 | 331.84M |
| May 06, 2024 | 336.89M |
| May 03, 2024 | 333.52M |
| May 02, 2024 | 322.57M |
| May 01, 2024 | 324.26M |
| April 30, 2024 | 311.63M |
| April 29, 2024 | 312.47M |
| April 26, 2024 | 312.47M |
| April 25, 2024 | 310.78M |
| April 24, 2024 | 311.63M |
| April 23, 2024 | 314.15M |
| April 22, 2024 | 309.10M |
| April 19, 2024 | 313.31M |
| April 18, 2024 | 311.63M |
| Date | Value |
|---|---|
| April 17, 2024 | 312.47M |
| April 16, 2024 | 314.99M |
| April 15, 2024 | 316.68M |
| April 12, 2024 | 316.68M |
| April 11, 2024 | 324.26M |
| April 10, 2024 | 317.52M |
| April 09, 2024 | 320.89M |
| April 08, 2024 | 316.68M |
| April 05, 2024 | 320.89M |
| April 04, 2024 | 324.26M |
| April 03, 2024 | 328.47M |
| April 02, 2024 | 325.94M |
| April 01, 2024 | 336.89M |
| March 28, 2024 | 340.02M |
| March 27, 2024 | 336.66M |
| March 26, 2024 | 317.30M |
| March 25, 2024 | 321.51M |
| March 22, 2024 | 341.71M |
| March 21, 2024 | 345.07M |
| March 20, 2024 | 332.45M |
| March 19, 2024 | 331.61M |
| March 18, 2024 | 336.66M |
| March 15, 2024 | 337.50M |
| March 14, 2024 | 324.03M |
| March 13, 2024 | 335.82M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
233.62M
Minimum
Nov 22 2023
7.291B
Maximum
Feb 08 2021
1.212B
Average
516.20M
Median
Apr 18 2022
Market Cap Benchmarks
| CEL-SCI Corp | 70.41M |
| AIM ImmunoTech Inc | 21.05M |
| IGC Pharma Inc | 33.59M |
| NovaBay Pharmaceuticals Inc | 5.289M |
| Protalix BioTherapeutics Inc | 94.58M |
Market Cap Related Metrics
| PS Ratio | 0.9082 |
| Price to Book Value | 0.6379 |
| Price | 3.82 |
| Earnings Yield | -51.31% |
| Operating PE Ratio | 2.306 |
| Normalized PE Ratio | 2.809 |